Publications by authors named "Pinky Gehlot"

Claim this Profile
G
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.
Aina Bellver-Sanchis, Marta Ribalta-Vilella, Alba Irisarri, Pinky Gehlot, Bhanwar Singh Choudhary

Med Res Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD).
Pinky Gehlot, Rekha Pathak, Sunil Kumar, Naveen Kumar Choudhary, Vivek Kumar Vyas

Bioorg Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
Pinky Gehlot, Vivek K Vyas

Recent Pat Anticancer Drug Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances on patents of dihydroorotate dehydrogenase (DHODH) inhibitors as antimalarial agents.
Pinky Gehlot, Vivek K Vyas

Expert Opin Ther Pat· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review.
Pinky Gehlot, Sunil Kumar, Vivek Kumar Vyas, Bhanwar Singh Choudhary, Manish Sharma

Bioorg Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19.
Shailendra Pratap Singh, Salomon Amar, Pinky Gehlot, Sanjib K Patra, Navjot Kanwar

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis